Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.

Authors :: De Meyer, Tim
Rietzschel, Ernst R.
De Buyzere, Marc L.
Langlois, Michel R.
De Bacquer, Dirk
Segers, Patrick
Van Damme, Piet
De Backer, Guy G.
Van Oostveldt, Patrick
Van Criekinge, Wim
Gillebert, Thierry C.
Bekaert, Sofie
Source :: European Heart Journal; Dec2009, Vol. 30 Issue 24, p3074-3081, 8p, 4 Charts, 2 Graphs
Publication Year :: 2009
Abstract: Aims: Peripheral blood leucocyte (PBL) telomere length (TL) is a systemic ageing biomarker and has been proposed to be an independent predictor of cardiovascular disease (CVD). We aimed at providing an explanation for this association by the evaluation of the biomarker value of PBL-TL in preclinical atherosclerosis. [ABSTRACT FROM PUBLISHER]

Tools